BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16817756)

  • 1. Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease.
    Tam PE
    Viral Immunol; 2006; 19(2):133-46. PubMed ID: 16817756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The group B coxsackieviruses and myocarditis.
    Kim KS; Hufnagel G; Chapman NM; Tracy S
    Rev Med Virol; 2001; 11(6):355-68. PubMed ID: 11746998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biology and pathogenesis of viral myocarditis.
    Esfandiarei M; McManus BM
    Annu Rev Pathol; 2008; 3():127-55. PubMed ID: 18039131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enterovirus-infected immune cells of spleen and lymph nodes in the murine model of chronic myocarditis: a role in pathogenesis?
    Klingel K; McManus BM; Kandolf R
    Eur Heart J; 1995 Dec; 16 Suppl O():42-5. PubMed ID: 8682099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of B lymphocytes in coxsackievirus B3 infection.
    Mena I; Perry CM; Harkins S; Rodriguez F; Gebhard J; Whitton JL
    Am J Pathol; 1999 Oct; 155(4):1205-15. PubMed ID: 10514403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism.
    Selinka HC; Wolde A; Sauter M; Kandolf R; Klingel K
    Med Microbiol Immunol; 2004 May; 193(2-3):127-31. PubMed ID: 12920584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of specific alphabeta+ T-cell subsets in the myocardium of patients with myocarditis and idiopathic dilated cardiomyopathy associated with Coxsackievirus B infection.
    Luppi P; Rudert W; Licata A; Riboni S; Betters D; Cotrufo M; Frati G; Condorelli G; Trucco M
    Hum Immunol; 2003 Feb; 64(2):194-210. PubMed ID: 12559622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CVB infection and mechanisms of viral cardiomyopathy.
    Knowlton KU
    Curr Top Microbiol Immunol; 2008; 323():315-35. PubMed ID: 18357777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coxsackievirus B3-induced myocarditis: differences in the immune response of C57BL/6 and Balb/c mice.
    Leipner C; Grün K; Schneider I; Glück B; Sigusch HH; Stelzner A
    Med Microbiol Immunol; 2004 May; 193(2-3):141-7. PubMed ID: 14593475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway.
    Shi Y; Fukuoka M; Li G; Liu Y; Chen M; Konviser M; Chen X; Opavsky MA; Liu PP
    Circulation; 2010 Jun; 121(24):2624-34. PubMed ID: 20530002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection.
    Yajima T
    Future Microbiol; 2011 May; 6(5):551-66. PubMed ID: 21585262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms and consequences of enterovirus persistence in cardiac myocytes and cells of the immune system.
    Kandolf R; Sauter M; Aepinus C; Schnorr JJ; Selinka HC; Klingel K
    Virus Res; 1999 Aug; 62(2):149-58. PubMed ID: 10507324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathogenesis of experimental Coxsackievirus induced myocarditis: role of autoimmunity.
    Huber SA; Lyden DC; Lodge PA
    Herz; 1985 Feb; 10(1):1-7. PubMed ID: 2984097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
    Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
    Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production.
    Fuse K; Chan G; Liu Y; Gudgeon P; Husain M; Chen M; Yeh WC; Akira S; Liu PP
    Circulation; 2005 Oct; 112(15):2276-85. PubMed ID: 16216974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulating intestinal immunity and microflora: an alternative solution to viral myocarditis?
    Qian Q; Xiong S; Xu W
    Future Microbiol; 2012 Oct; 7(10):1207-16. PubMed ID: 23030425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease.
    Tracy S; Chapman NM; Romero J; Ramsingh AI
    Trends Microbiol; 1996 May; 4(5):175-9. PubMed ID: 8727596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.
    Dunn JJ; Bradrick SS; Chapman NM; Tracy SM; Romero JR
    J Infect Dis; 2003 May; 187(10):1552-61. PubMed ID: 12721935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmunity in myocarditis: models and mechanisms.
    Rose NR; Herskowitz A; Neumann DA
    Clin Immunol Immunopathol; 1993 Aug; 68(2):95-9. PubMed ID: 8395364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy.
    Chapman NM; Kim KS
    Curr Top Microbiol Immunol; 2008; 323():275-92. PubMed ID: 18357775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.